Your browser doesn't support javascript.
loading
First-in-Humans Study of the SSTR Antagonist 177Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy.
Baum, Richard P; Zhang, Jingjing; Schuchardt, Christiane; Müller, Dirk; Mäcke, Helmut.
Afiliação
  • Baum RP; Theranostics Center for Molecular Radiotherapy and Precision Oncology, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.
  • Zhang J; CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany.
  • Schuchardt C; Theranostics Center for Molecular Radiotherapy and Precision Oncology, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany; zhangjingjingtag@163.com.
  • Müller D; Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore, Singapore.
  • Mäcke H; Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; and.
J Nucl Med ; 62(11): 1571-1581, 2021 Nov.
Article em En | MEDLINE | ID: mdl-33674401
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Tipo de estudo: Guideline Limite: Adult / Aged / Humans / Middle aged Idioma: En Revista: J Nucl Med Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores Neuroendócrinos / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Tipo de estudo: Guideline Limite: Adult / Aged / Humans / Middle aged Idioma: En Revista: J Nucl Med Ano de publicação: 2021 Tipo de documento: Article